Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Valneva SE (VALN) and Encourages Investors to Learn More About the Investigation
NEW YORK CITY, NY / ACCESS Newswire / March 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...
Valneva SE (VALN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
NEW YORK CITY, NY / ACCESS Newswire / March 11, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...
Yahoo Finance2d
Valneva SE (VALN)
2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) a specialty vaccine company, today announced that its senior management will participate at upcoming investor conferences in the United ...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Valneva SE - VALN
On February 25, 2025, the U.S. Centers for disease Control and Prevention ("CDC") posted a notice on its website announcing that "CDC is currently investigating five hospitalizations for cardiac or ...
ETF Daily News4d
Valneva (NASDAQ:VALN) Shares Gap Up – Time to Buy?
Shares of Valneva SE (NASDAQ:VALN – Get Free Report) gapped up before the market opened on Friday . The stock had previously closed at $6.86, but opened at $7.11. Valneva shares last traded at $ ...
TMCnet12d
Valneva Receives EMA's Positive CHMP Opinion for Adolescent Label Extension for Chikungunya Vaccine IXCHIQ®
If granted, IXCHIQ ® will become the first vaccine against the chikungunya virus (CHIKV) available in the EU for adolescents 12 years of age and older Saint Herblain (France), February 28, 2025 – ...
ETF Daily News18d
HC Wainwright Predicts Valneva’s Q4 Earnings (NASDAQ:VALN)
Valneva SE (NASDAQ:VALN – Free Report) – Stock analysts at HC Wainwright lowered their Q4 2024 EPS estimates for shares of Valneva in a report issued on Wednesday, February 19th.HC Wainwright ...
Benzinga.com22d
4 Analysts Have This To Say About Valneva
Stay informed and make well-considered decisions with our Ratings Table. Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for ...
Morningstar8d
Valneva SE ADR VALN
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Morningstar12d
Valneva Receives EMA’s Positive CHMP Opinion for Adolescent Label Extension for Chikungunya Vaccine IXCHIQ®
2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines ...
Investing20d
Valneva SE ADR (VALN)
This page features the latest news about the Valneva SE stock. H.C. Wainwright cuts Valneva stock target to $17, maintains Buy On Tuesday, H.C. Wainwright analyst Edward White adjusted the price ...
Taiwan News12d
Valneva Receives EMA’s Positive CHMP Opinion for Adolescent Label Extension for Chikungunya Vaccine IXCHIQ®
If granted, IXCHIQ ® will become the first vaccine against the chikungunya virus (CHIKV) available in the EU for adolescents 12 years of age and older Saint Herblain (France), February 28, 2025 – ...